18+ · Research use only
Survodutide Philippines
Survodutide is a peptide sold by Primara Labs for research use only. It sells as a 10 pack at ₱2,624 a vial, with a single vial at ₱4,290 on request. Preorder. Dispatches in about 2 weeks. Lab testing: no report published yet, scheduled, see primaralabs.com/coa.
Peptide studied in Phase 3 human trials. Lyophilized powder, on preorder in 10 packs. For laboratory research use only.
Sold as a 10 pack
Pack price replaces the 10% off. One compound per pack.
Pack price replaces the standing 10% off; they don't stack. One compound per pack.
Single vial ₱4,290, on request
Request a single vialCheck out once for the whole cart. Pay by QR, confirm on WhatsApp.
Add more compounds if you like, then check out once. You pay by QR on your order page and send the screenshot on WhatsApp.
In the Philippines
GCash · Maya · QR Ph bank transfer · InstaPay
From abroad
- International transfer
Wise · International bank transfer · Zelle · Crypto
Payment details are sent in the WhatsApp chat once your order is confirmed.
Preorder. Dispatches in about 2 weeks.
Includes water, syringes, pads · plain box
60-day money-back guaranteeTerms
Preorder. Dispatches in about 2 weeks.
Free courier nationwide · Luzon 1-2 days · Visayas 2-3 days · Mindanao 3-5 days
Everything to reconstitute is included
10 x 3ml water · 100 syringes · 100 pads · plain outer packaging
60-day money-back guarantee
If an accredited independent laboratory reports that this vial is not the compound on the label, we refund what you paid for it. Evidence within 60 calendar days of delivery; you do not send anything back. Terms
Delivery proof
Real orders, really delivered

Metro Manila · Same-day
Shipped 1:57 PM, received 2:33 PM. Same day, 36 minutes.

Metro Manila · Customer reply
"Surprised din po ako. Magoorder ako ulit kapag naubos na." They came back and reordered.

Quezon City · Repeat customer
Delivered 11:34 PM. Three weeks later: "Can I order again." "Primara I can say was the best choice."
Real WhatsApp and courier screenshots. Names, numbers and addresses are blacked out.
Updated 16 November 2026
- Human evidence
- Phase 3
- Manufacturing
- cGMP · ISO 9001 · ISO 13485
- Latest batch report
- Scheduled, see /coa
- Storage
- 2 to 8 °C sealed
Survodutide in the Philippines
Survodutide is an investigational peptide from Boehringer Ingelheim that activates two receptors, GLP-1 and glucagon. The glucagon arm is studied for energy expenditure and liver fat, which is why its trials cover fatty liver disease with inflammation (MASH) as well as obesity.
SYNCHRONIZE-1, a phase 3 trial in adults with obesity or overweight, reported more body-weight reduction on survodutide than on placebo; the figure, the estimand it was measured under and the adverse events are set out in the research section below. Gastrointestinal effects were the most common adverse events. It is approved nowhere; phase 3 trials in MASH are running.
Survodutide is on preorder and sells in 10 packs of 10mg vials. Preorder. Dispatches in about 2 weeks. Because the wait is longer, we confirm the date in the chat and take payment only once it is agreed. Keep the vials refrigerated and sealed until use. The incretin compounds held in Manila stock are covered in the philippinespeptides.com incretin guides.
Regulatory status
Survodutide. FDA Philippines: not established. US FDA: Investigational, approved for no use. Phase 3 trials in MASH (LIVERAGE) under way at Boehringer Ingelheim. Checked 16 November 2026.
Sold for laboratory research only, not for human consumption. Primara Labs does not give medical advice or dosing guidance. Regulatory Status Tracker
Laboratory handling
Reconstitution reference
| BAC water added | Resulting concentration | Note |
|---|---|---|
| 1.0 ml | 10 mg/ml | Highest concentration, smallest volumes |
| 2.0 ml | 5 mg/ml | Common reference dilution |
Reconstitute with bacteriostatic water. Reference values are for laboratory preparation only. Other volumes: reconstitution calculator, prefilled for Survodutide 10mg.
Handling and storage
Sealed vials
Store sealed lyophilised vials refrigerated at 2 to 8 °C, away from light.
Primara Labs storage instructionAdding diluent
Add the diluent slowly down the inside wall of the vial rather than straight onto the powder.
Mixing
The US prescribing instructions for tesamorelin, a lyophilised peptide medicine, tell users to swirl the vial to mix the powder and liquid, and not to shake it.
Tesamorelin US instructions for use, DailyMed · checked 23 September 2026Appearance
The same instructions say not to use the solution if it is cloudy, discoloured or has particles in it.
Tesamorelin US instructions for use, DailyMed · checked 23 September 2026After the stopper is punctured
CDC guidance, citing USP chapter 797, is that a multi-dose vial once opened is dated and discarded within 28 days unless the manufacturer states another date, and never used past its original expiry.
CDC, Preventing Unsafe Injection Practices · checked 23 September 2026Benefits studied
Body-weight reduction
Phase 3 humanIn SYNCHRONIZE-1, a 76-week phase 3 trial of 725 adults with obesity or overweight without type 2 diabetes, mean body weight fell 16.6% on survodutide against 3.2% on placebo (efficacy estimand, as reported by the sponsor).
SYNCHRONIZE-1, N Engl J Med 2026 · checked 16 November 2026Liver inflammation in MASH
Phase 2 humanIn a 48-week phase 2 trial in adults with biopsy-confirmed MASH and fibrosis stages F1 to F3, improvement in MASH without worsening of fibrosis occurred in 43% to 62% across the survodutide arms against 14% on placebo.
Sanyal AJ et al. N Engl J Med 2024, PubMed 38847460 · checked 16 November 2026Liver fibrosis in MASH
Phase 2 humanIn the same 48-week phase 2 MASH trial, fibrosis improved by at least one stage in 34% to 36% across the survodutide arms against 22% on placebo.
Sanyal AJ et al. N Engl J Med 2024, PubMed 38847460 · checked 16 November 2026Body-weight reduction in a dose-finding trial
Phase 2 humanIn a 46-week phase 2 dose-finding trial in adults with a BMI of 27 or more and no diabetes, mean body weight fell by up to 14.9% on survodutide against 2.8% on placebo in the planned-treatment analysis.
le Roux CW et al. Lancet Diabetes Endocrinol 2024 · checked 16 November 2026
Side effects reported
In the 48-week phase 2 MASH trial, nausea (66% against 23% on placebo) and diarrhoea (49% against 23%) were more frequent on survodutide, as was vomiting.
Sanyal AJ et al. N Engl J Med 2024, PubMed 38847460 · checked 16 November 2026In the 46-week phase 2 obesity trial, gastrointestinal disorders were the most frequently reported adverse events, and 24.6% of participants on survodutide stopped treatment, mostly in the first 20 weeks.
le Roux CW et al. Lancet Diabetes Endocrinol 2024 · checked 16 November 2026In the 76-week phase 3 SYNCHRONIZE-1 trial, nausea, vomiting, diarrhoea and constipation occurred more often on survodutide than on placebo, mostly early in the trial.
SYNCHRONIZE-1, N Engl J Med 2026 · checked 16 November 2026Findings are described as the research reported them, with the level of evidence for each. They are not a claim about any vial sold here, which is supplied for laboratory research use only.
How it works
Survodutide is a single peptide that activates two receptors, the GLP-1 receptor and the glucagon receptor. Boehringer Ingelheim is studying it for obesity and for fatty liver disease with inflammation (MASH).
Targets: Glucagon and GLP-1 receptors
What the research shows
Survodutide is an investigational peptide from Boehringer Ingelheim that activates the GLP-1 and glucagon receptors, approved nowhere. In the phase 3 SYNCHRONIZE-1 trial, adults with obesity or overweight lost a mean 16.6% of body weight over 76 weeks against 3.2% on placebo (efficacy estimand), and a phase 2 trial in MASH reported improvement in liver inflammation more often than placebo. Nausea, vomiting and diarrhoea were the most common adverse events.
Lab report: scheduled, see primaralabs.com/coa. No batch report for Survodutide is published yet.
- Type
- Glucagon and GLP-1 receptor dual agonist
- Presentation
- Lyophilized powder, 10 mg / vial
- Vial size
- 10mg
- Catalogue code
- PRM-034
PubChem could not be reached when this SKU was added on 16 November 2026, so no formula, weight or CAS is published from it yet.
Preorder. Dispatches in about 2 weeks. The windows below run from that dispatch, once the box has arrived from the supplier.
Frequently asked
Survodutide questions, answered
How much is Survodutide in the Philippines?
At Primara Labs, Survodutide 10mg sells as a 10 pack at ₱2,624 per vial (₱26,240 total). A single vial is ₱4,290, available on request on WhatsApp. Prices are in pesos and the pack price is shown on the product page before you order.
Where can I buy Survodutide in the Philippines?
Primara Labs sells Survodutide 10mg on preorder, as a 10 pack. Preorder. Dispatches in about 2 weeks. Two ways to order: add to cart and pay by QR (GCash, Maya, QR Ph, InstaPay), or message us on WhatsApp to pay by Wise, international bank transfer, Zelle or crypto.
Do you deliver Survodutide to Cebu, Davao and the provinces?
Yes. Preorder. Dispatches in about 2 weeks. From dispatch: Metro Manila: same day before 12 noon, Grab Express / Lalamove, ₱150; Luzon: 1 to 2 business days, J&T Express, ₱250; Visayas: 2 to 3 business days, J&T Express, ₱250; Mindanao: 3 to 5 business days, J&T Express, ₱300. Cebu is in the Visayas and Davao in Mindanao. Courier is free on orders over ₱10,000 anywhere in the Philippines. Below that, a Metro Manila rider is ₱150, J&T Express is ₱250 to Luzon and the Visayas and ₱300 to Mindanao.
Is Survodutide FDA approved in the Philippines?
Survodutide. FDA Philippines: not established. US FDA: Investigational, approved for no use. Phase 3 trials in MASH (LIVERAGE) under way at Boehringer Ingelheim. Checked 16 November 2026. Primara Labs supplies it for research use only; it is not for human consumption.
Is Survodutide on preorder?
Yes. Survodutide is on preorder: the supplier's lead time is longer than for the rest of the catalogue. Preorder. Dispatches in about 2 weeks. The order is confirmed and the total agreed in the WhatsApp chat before anything is paid.
Why is this sold as a 10-pack?
Survodutide is sold in 10-packs, at ₱2,624 per vial. Single vials are available on request via WhatsApp at ₱4,290. Preorder. Dispatches in about 2 weeks.
What is Survodutide studied for?
Survodutide is an investigational peptide from Boehringer Ingelheim that activates the GLP-1 and glucagon receptors, approved nowhere. In the phase 3 SYNCHRONIZE-1 trial, adults with obesity or overweight lost a mean 16.6% of body weight over 76 weeks against 3.2% on placebo (efficacy estimand), and a phase 2 trial in MASH reported improvement in liver inflammation more often than placebo. Nausea, vomiting and diarrhoea were the most common adverse events.
What side effects were reported for Survodutide?
In the 48-week phase 2 MASH trial, nausea (66% against 23% on placebo) and diarrhoea (49% against 23%) were more frequent on survodutide, as was vomiting. In the 46-week phase 2 obesity trial, gastrointestinal disorders were the most frequently reported adverse events, and 24.6% of participants on survodutide stopped treatment, mostly in the first 20 weeks. In the 76-week phase 3 SYNCHRONIZE-1 trial, nausea, vomiting, diarrhoea and constipation occurred more often on survodutide than on placebo, mostly early in the trial.
How should Survodutide be stored?
Store sealed lyophilised vials refrigerated at 2 to 8 °C, away from light. CDC guidance, citing USP chapter 797, is that a multi-dose vial once opened is dated and discarded within 28 days unless the manufacturer states another date, and never used past its original expiry.
Does Primara Labs publish lab reports for Survodutide?
Lab report: scheduled, see primaralabs.com/coa. No batch report for Survodutide is published yet.
All compounds supplied by Primara Labs are for laboratory research use only and are not for human consumption, diagnostic or therapeutic use. Statements on this page describe published research and have not been evaluated by the Philippine FDA. See Research Use Only terms.
